Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit

Phytotherapy Research

Volumn 13, Issue 3, 1999, Pages 192-196

  Sekiya, Nobuyasu ^a   Tanaka, Nobumitsu ^a   Itoh, Takashi ^a   Shimada, Yutaka ^a   Goto, Hirozo ^a   Terasawa, Katsutoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Antioxidative effect; Atherosclerosis; Cholesterol fed rabbit; Keishi bukuryo gan; Polyphenolic substance

Indexed keywords

CHOLESTEROL; KEISHI BUKURYO GAN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID OXIDATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; THORACIC AORTA;

ANIMALS; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DRUGS, CHINESE HERBAL; LIPID PEROXIDATION; MALE; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032892765     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199905)13:3<192::AID-PTR412>3.0.CO;2-2     Document Type: Article

References (22)

1. Asai, K., Funaki, C., Hayashi, T. et al. (1993). Dexamethasone-induced suppression of atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. 13, 892-899.
2. Brown, M. S. and Goldstein, J. L. (1976). Receptor-mediated control of cholesterol metabolism. Science 191, 150-154.
3. Frankel, E. N., Kanner, J., German, J. B., Parkes, E. and Kinsela, J. E. (1993). Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457.
4. Goldberg, D. M., Tsang, E., Karumanchiri, A., Diamandis, E. P., Soleas, G. and Ng, E. (1996). Method to assay the concentration of phenolic constituents of biological interest in wines. Anal. Chem. 68, 1688-1694.
5. Haberland, M. E., Fong, D. and Cheng, L. (1988). Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241, 215-218.
6. Heinecke, J. W., Rosen, H. and Chait, A. (1984). Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74, 1890-1894.
7. Itoh, T., Terasawa, K., Kohta, K., Shibahara, N., Tosa, H. and Hiyama, Y. (1992). Effects of keishi-bukuryo-gan and trapidil on the microcirculation in patients with cerebrospinal vascular disease. J. Med. Pharm. Soc. for Wakan-Yaku 9, 40-46.
8. Keaney, J. F. (1995). Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and Superoxide generation. J. Clin. Invest. 95, 2520-2529.
9. Kita, T., Nagano, Y., Yokode, M. et al. (1987). Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl Acad. Sci. USA 84, 5928-5931.
10. Kohta, K., Hikiami, H., Shimada, Y., Matsuda, H., Hamazaki, T. and Terasawa, K. (1993). Effects of Keishi-bukuryo-gan on erythrocyte aggregability in patients with multiple old lacunar infarction. J. Med. Pharm. Soc. Wakan-Yaku 10, 251-259.
11. Kugiyama, K., Kerns, S. A., Morisett, J. D., Roberts, R. and Henry, P. D. (1990). Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344, 160-162.
12. Kume, N., Cybulsky, M. I. and Gimbrone, M. A. Jr. (1992). Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90, 1138-1144.
13. Kume, N. and Gimbrone, M. A. Jr. (1994). Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93, 907-911.
14. McMurray, H. F., Parathasarathy, S. and Steinberg, D. (1993). Oxidatively modified low density lipoprotein is a chemoattractantfor human T lymphocytes. J. Clin. Invest. 92, 1004-1008.
15. Ohara, Y., Peterson, T. E., Zheng, B., Kuo, J. F. and Harrison, D. G. (1994). Lysophosphatidylcholine increases vascular Superoxide anion production via protein kinase C activation. Arterioscler. Thromb. 14(6), 1007-1013.
16. Okuda, T. (1991). Traditional medicine. J. Act. Oxygens Free Rad. 2, 197-201.
17. Palinski, W., Rosenfeld, M. E., Yla-Herttuala, S. et al. (1989). Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl Acad. Sci. 86, 1372-1376.
18. Quinn, M. T., Parthasarathy, S. and Steinberg, D. (1988). Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc. Natl Acad. Sci. USA 85, 2805-2809.
19. Steinbrecher, U. P. (1988). Role of Superoxide in endothelialcell modification of low density lipoproteins. Biochem. Biophys. Acta 959, 20-30.
20. Takahashi, S., Kawarabayashi, Y., Nakai, T., Sakai, J. and Yamamoto, T. (1992). Rabbit very low density lipoprotein receptor. A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl Acad. Sci. USA 89, 9252-9256.
21. Tall, A. R. (1990). Plasma high density lipoproteins. J. Clin. Invest. 86, 379-384.
22. Terasawa, K. (1993). Kampo Japanese-Oriental Medicine, pp 43-51, pp 200-201. K. K. Standard McIntyre, Tokyo, Japan.